MEK inhibition in non-small cell lung cancer
TE Stinchcombe, GL Johnson - Lung cancer, 2014 - Elsevier
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
[HTML][HTML] MEK Inhibition in Non-Small Cell Lung Cancer
TE Stinchcombe, GL Johnson - Lung cancer (Amsterdam …, 2014 - ncbi.nlm.nih.gov
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
MEK inhibition in non-small cell lung cancer.
TE Stinchcombe, GL Johnson - Lung Cancer (Amsterdam …, 2014 - europepmc.org
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
MEK inhibition in non-small cell lung cancer
TE Stinchcombe, GL Johnson - Lung Cancer, 2014 - infona.pl
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
[引用][C] MEK inhibition in non-small cell lung cancer
TE STINCHCOMBE, GL JOHNSON - Lung cancer, 2014 - pascal-francis.inist.fr
MEK inhibition in non-small cell lung cancer CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
MEK inhibition in non-small cell lung cancer
TE Stinchcombe, GL Johnson - Lung Cancer (Amsterdam …, 2014 - cdr.lib.unc.edu
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
MEK inhibition in non-small cell lung cancer
TE Stinchcombe, GL Johnson - Lung cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
MEK inhibition in non-small cell lung cancer
TE Stinchcombe, GL Johnson - Lung Cancer, 2014 - lungcancerjournal.info
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF–MEK …
MEK inhibition in non-small cell lung cancer.
TE Stinchcombe, GL Johnson - Lung Cancer (Amsterdam …, 2014 - europepmc.org
KRAS mutations are the most common mutations in non-small cell lung cancer (NSCLC)
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …
with adenocarcinoma histology. KRAS mutations result in the activation of the RAF-MEK …